Pharma Connections

PHARMAQ is a global leader in vaccine development and innovation for the aquaculture industry, providing environmentally sound and effective health products. With production facilities, research and development activities, and administration based in Norway, PHARMAQ has subsidiaries in several countries, including Chile, United Kingdom, Vietnam, Turkey, Spain, Panama, and Hong Kong. With a commitment to targeted research and a dedicated team, PHARMAQ supports sustainable growth in the global aquaculture industry. Their products are marketed in Europe, North and South America, and Asia, offering high-quality vaccination machinery and equipment, diagnostics advice, and a range of products and services for fish health and welfare.Generated from the website

Dr. Raju's Pharma Solutions, LLC (DRRPSL) is a wholesale distributor licensed in New York, New Jersey, and Pennsylvania, providing technical guidance to the pharmaceutical industry for over 20 years. They offer a full spectrum of solutions, including contract research, custom synthesis, and formulation manufacturing, with a network of reputed partners supporting the supply of API and drug intermediates for OTC, ANDA, and NDA drug development. Their mission is to ensure timely and cost-effective supplies without compromising excellent quality by leveraging their well-established strategic alliances with ethical manufacturers globally. They work closely with Reliable, an independent 3PL recognized for developing innovative supply chain solutions, to store pharmaceutical products securely and provide services for medical device manufacturers, cosmetics, and health and wellness companies.Generated from the website

BioWa, Inc. is a New Jersey-based biotech company and a wholly owned subsidiary of Kyowa Kirin Co, Ltd. Established in 2003, BioWa is dedicated to advancing health through innovations in life science and technology, specializing in the out-licensing of Kyowa Kirin's Therapeutic Antibody Technologies, POTELLIGENT and COMPLEGENT. The company's name, BioWa, symbolizes the harmonious fusion of American and Japanese sensibilities, reflecting their earnest mission to enhance the quality of life for all. As the exclusive worldwide licensor of POTELLIGENT Technology, BioWa offers a proprietary technology that generates fucose-free monoclonal antibodies with significantly increased antibody-dependent cellular cytotoxicity (ADCC), bolstering the immune system's ability to eliminate tumor cells. Additionally, BioWa holds the exclusive global license for COMPLEGENT Technology, a robust platform that enhances complement-dependent cytotoxicity (CDC) of therapeutic antibodies. By combining these technologies, BioWa introduces the AcrretaMab platform, a novel class of antibodies designed to combat various life-threatening diseases, including cancer.Generated from the website